We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.77%
4 Financials 5.47%
5 Communication Services 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRA
2976
DELISTED
ProAssurance
PRA
$1.03M ﹤0.01%
74,652
+13,108
+21% +$201K
LOVE
2977
PUT
LoveSac
LOVE
$233M
$1.02M ﹤0.01%
40,000
-89,700
-69% -$1.8M
PERI icon
2978
CALL
Perion Network
PERI
$385M
$1.02M ﹤0.01%
33,100
BTU icon
2979
PUT
Peabody Energy
BTU
$3.35B
$1.02M ﹤0.01%
+42,000
New +$1.01M
BY icon
2980
Byline Bancorp
BY
$1.72B
$1.02M ﹤0.01%
43,348
-15,909
-27% -$330K
API
2981
Agora
API
$348M
$1.02M ﹤0.01%
386,830
-38,454
-9% -$107K
CRCT icon
2982
Cricut
CRCT
$1.23B
$1.02M ﹤0.01%
+154,244
New +$1.19M
CDMO
2983
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.02M ﹤0.01%
156,308
+51,680
+49% +$333K
RKT icon
2984
CALL
Rocket Companies
RKT
$40.5B
$1.01M ﹤0.01%
70,000
CLAR icon
2985
Clarus
CLAR
$145M
$1.01M ﹤0.01%
146,794
+39,661
+37% +$233K
IMTXW
2986
DELISTED
Immatics N.V. Warrants
IMTXW
$1.01M ﹤0.01%
346,518
+57,627
+20% +$147K
IWB icon
2987
iShares Russell 1000 ETF
IWB
$48.9B
$1.01M ﹤0.01%
+3,853
New +$943K
VDE icon
2988
Vanguard Energy ETF
VDE
$10.6B
$1.01M ﹤0.01%
+8,599
New +$1.03M
GLAC
2989
DELISTED
Global Lights Acquisition Corp Ordinary Shares
GLAC
$1.01M ﹤0.01%
+100,000
New +$1.01M
HRT
2990
DELISTED
HireRight Holdings Corporation
HRT
$1M ﹤0.01%
74,550
+8,975
+14% +$102K
KVAC
2991
DELISTED
Keen Vision Acquisition Corp
KVAC
$1M ﹤0.01%
97,000
TEL icon
2992
TE Connectivity
TEL
$58.3B
$1M ﹤0.01%
7,123
-263,560
-97% -$33.9M
FBIN icon
2993
Fortune Brands Innovations
FBIN
$5.45B
$1,000K ﹤0.01%
+13,132
New +$864K
OPEN icon
2994
PUT
Opendoor
OPEN
$3.5B
$999K ﹤0.01%
230,433
+13,433
+6% +$37.5K
FLG
2995
Flagstar Bank National Association
FLG
$5.58B
$994K ﹤0.01%
+32,374
New +$971K
IEO icon
2996
iShares US Oil & Gas Exploration & Production ETF
IEO
$606M
$992K ﹤0.01%
+10,638
New +$1.01M
TMDX icon
2997
Transmedics
TMDX
$3.25B
$992K ﹤0.01%
+12,564
New +$758K
BXMT icon
2998
Blackstone Mortgage Trust
BXMT
$2.36B
$991K ﹤0.01%
+46,603
New +$1M
PAX icon
2999
Patria Investments
PAX
$1.9B
$991K ﹤0.01%
63,876
-70,717
-53% -$1M
MATW icon
3000
Matthews International
MATW
$671M
$989K ﹤0.01%
+26,981
New +$989K

Similar funds

David Shaw's Q4 2023 Portfolio in Review

As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
  • David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • David Shaw opened 575 new positions and closed 527 in Q4 2023.
  • David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.